Evidence map›Paper›PMID 40642196›Full record

ArticlePolish journal of radiology2025

Recommendations of the Polish Medical Radiological Society regarding MRI in patients with plexiform neurofibromas in the course of neurofibromatosis type 1.

Zbigniew Serafin, Magdalena Machnikowska-Sokołowska, Elżbieta Zawada, Monika Bekiesińska-Figatowska, Agata Hałabuda, Marta Bladowska, Grzegorz Wasilewski, Dobromiła Barańska, Agata Szczurowska, Marek Karwacki and 2 more

Abstract read
In one paragraph

Article in Polish journal of radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Zbigniew SerafinFaculty of Medical Sciences, Bydgoszcz University of Science and Technology, Bydgoszcz, Poland.
Magdalena Machnikowska-SokołowskaDepartment of Diagnostic Imaging, Radiology and Nuclear Medicine, Faculty of Medical Science in Katowice, Medical University of Silesia in Katowice, Poland.
Elżbieta ZawadaDepartment of Radiology and Diagnostic Imaging, Nicolaus Copernicus University, Collegium Medicum, Bydgoszcz, Poland.
Monika Bekiesińska-FigatowskaDepartment of Diagnostic Imaging, Institute of Mother and Child, Warsaw, Poland.
Agata HałabudaDepartment of Radiology, Polish-American Institute of Paediatrics, Jagiellonian University, Krakow, Poland.
Marta BladowskaDepartment of Paediatric Radiology, Regional Specialised Children's Hospital, Olsztyn, Poland.
Grzegorz WasilewskiDepartment of Paediatric Radiology, Regional Specialised Children's Hospital, Olsztyn, Poland.
Dobromiła BarańskaDepartment of Diagnostic Imagining, Polish Mother's Memorial Hospital - Research Institute, Lodz, Poland.
Agata SzczurowskaDepartment of General Radiology, Interventional Radiology, and Neuroradiology, Wroclaw Medical University, Wroclaw, Poland.
Marek KarwackiCoordinated Medical Care Centre for Neurofibromatoses and Related RASopathies, Department of Paediatrics, Haematology, and Oncology, Medical University of Warsaw, Warsaw, Poland.
Katarzyna GarusDepartment of Paediatric Oncology and Haematology, Institute of Paediatrics, Jagiellonian University Medical College, Krakow, Poland.
Jan StyczyńskiDepartment of Paediatric Haematology and Oncology, Collegium Medicum, Nicolaus Copernicus University in Torun, Bydgoszcz, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurofibromatosis type 1 (NF1) is a genetically determined disorder with a complex clinical picture, including disorders of many systems and organs, that predisposes to the development of various cancers. Approximately 10-30% of patients with NF1 develop plexiform neurofibromas (PN), non-malignant tumours growing along the nerves, tending to infiltrate nerves and nerve plexuses, and may grow into internal organs, the spinal canal, and middle ear, deforming bones and various regions of the body. Magnetic resonance imaging (MRI) plays a key role in the management of individuals during the course of PN, as a screening tool at baseline, for surveillance (in individuals with known PN), to evaluate treatment response, and for preoperative assessment for surgical planning. The practical recommendations presented in this article aim to standardise the protocol for MRI examination of PN in the course of NF1 for the purpose of treatment in a clinical program in Poland. The protocol, covering volumetric MRI examination, imaging schedule, determination of the target change, the technique for measuring the volume of lesions, and suspected malignant transformation, is intended to be the minimum set of MRI sequences and views that must be included in every examination of these patients.

Indexed as

magnetic resonance imagingneurofibromatosis type 1plexiform neurofibromas

Identifiers

PMID40642196
PMCPMC12243518

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.